Protalix BioTherapeutics
PLX
#8741
Rank
$0.16 B
Marketcap
$2.07
Share price
3.50%
Change (1 day)
-8.81%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: $0.16 Billion USD

As of January 2026 Protalix BioTherapeutics has a market cap of $0.16 Billion USD. This makes Protalix BioTherapeutics the world's 8741th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026$0.16 B14.36%
2025$0.14 B8.02%
2024$0.13 B3.77%
2023$0.12 B87.08%
2022$69.41 M83.2%
2021$37.88 M-68.69%
2020$0.12 B148.64%
2019$48.66 M5.47%
2018$46.14 M-50.05%
2017$92.38 M67.73%
2016$55.08 M-45.89%
2015$0.10 B-40.9%
2014$0.17 B-52.64%
2013$0.36 B-25.05%
2012$0.48 B14.95%
2011$0.42 B-47.68%
2010$0.80 B50.76%
2009$0.53 B283.05%
2008$0.13 B-45.77%
2007$0.25 B-75.03%
2006$1.03 B4063.51%
2005$24.78 M4150%
2004$0.58 M-50%
2003$1.16 M263.64%
2002$0.32 M-52.17%
2001$0.67 M-8.84%
2000$0.73 M-7.84%
1999$0.79 M-86.03%
1998$5.71 M-75.09%
1997$22.94 M

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Protalix BioTherapeutics was reported to be:

$0.16 Billion USD
by Nasdaq info icon info icon
$0.16 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amicus Therapeutics
FOLD
$4.41 B 2,553.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$13.53 B 8,032.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$144.87 B 86,924.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$36.72 B 21,960.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel